Poll: In Light of the New Information Will You Start Recommending HRT for your Menopausal Patients?
In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research.
In a re-analysis of the WHI study 2002, the risks of HRT where misrepresented by the media and not corrected by those affiliated with the research. According to the International Menopause Society, women needlessly suffer through severe menopause symptoms because of this. While there is a risk with HRT, it is modest with a slight increased risk of stroke, venous thromboembolism, and breast cancer. The benefits to women include an improved quality of life, reduced risk of heart disease, colorectal cancer, dementia and bone fracture. In light of the new information will you start recommending HRT for your menopausal patients?
Low creatinine-to-cystatin C ratio linked to postmenopausal muscle loss
March 20th 2025A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.
Read More
